Treatment type: Precision medicine

For the first time the mechanism that spreads antimicrobial resistance inside the human gut has been identified in the lab.…  Read more

A world-first study at Hudson Institute has taken a big step to understanding the causes of neonatal brain injury…  Read more

A colon cancer research breakthrough at Hudson Institute has shown that combining two types of drugs targeting gene expression stops cancer proliferation.…  Read more

Hudson Institute scientists have found that a hormone that can cause high blood pressure has been found to behave differently in young men and women, possibly paving the way for more targeted diagnosis and treatment.…  Read more

The first osteoporosis screening program to identify patients at high risk of fracture following stroke will be established, after the Bone Health Foundation awarded Hudson Institute a $25,000 grant.…  Read more

Congratulations to Professor Brendan Jenkins and his team, who have been awarded $288,536 from Cancer Council Victoria (CCV) to fund research into pancreatic cancer.…  Read more

Bone cancer treatments will be progressed thanks to the Victorian Cancer Agency Early Career Fellowship, which has been awarded to Dr Vijesh Vaghjiani, Postdoctoral Scientist, Developmental and Cancer Biology Research group.…  Read more

Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

High-tech images have revealed for the first time that preterm babies on ventilators could be at risk of brain injury, leading to calls for caution during treatment.…  Read more

Melbourne researchers have published a breakthrough study that will accelerate new treatments for an often-fatal disease affecting premature babies in intensive care, called necrotising enterocolitis (NEC).…  Read more